Abalone Haliotis discus hannai Intestine Digests with Different Molecule Weights Inhibit MMP-2 and MMP-9 Expression in Human Fibrosarcoma Cells
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
The abalone Haliotis discus hannai, is one of the economically important species in the fisheries industry. Abalone intestines are one of the by-products of its processing. To investigate its bioactive potential, abalone intestine was digested using an in vitro gastrointestinal (GI) digestion system containing pepsin, trypsin, and α-chymotrypsin. The abalone intestine G1 digests (AIGIDs) produced by the GI digestion system were fractionated into AIGID I (> 100 kDa), AIGID II (10-100 kDa), and AIGID III (1-10 kDa)using an ultrafiltration membrane system. Of the three digests, AIGID II and AIGID III exhibited inhibitory effects against matrix metalloproteinase-2 and -9 (MMP-2, MMP-9) in HT1080 human fibrosarcoma cells. Both fractions potently inhibited gelatine digestion by MMP-2 and MMP-9 treated with phorbol 12-myristate 13-acetate (PMA) and migration of HT1080 cells in dose dependently. Furthermore, AIGID II and III attenuated expression of p65, a component of nuclear transcription factor kappa B. These results indicate that of the abalone intestine digests inhibit MMP-2 and MMP-9. Thus, the AIGIDs or their active components may have preventive and therapeutic potential for diseases associated with MMP-2 and MMP-9 activation in fibrosarcoma cells.
Abstract
The abalone Haliotis discus hannai, is one of the economically important species in the fisheries industry. Abalone intestines are one of the by-products of its processing. To investigate its bioactive potential, abalone intestine was digested using an in vitro gastrointestinal (GI) digestion system containing pepsin, trypsin, and α-chymotrypsin. The abalone intestine G1 digests (AIGIDs) produced by the GI digestion system were fractionated into AIGID I (> 100 kDa), AIGID II (10-100 kDa), and AIGID III (1-10 kDa)using an ultrafiltration membrane system. Of the three digests, AIGID II and AIGID III exhibited inhibitory effects against matrix metalloproteinase-2 and -9 (MMP-2, MMP-9) in HT1080 human fibrosarcoma cells. Both fractions potently inhibited gelatine digestion by MMP-2 and MMP-9 treated with phorbol 12-myristate 13-acetate (PMA) and migration of HT1080 cells in dose dependently. Furthermore, AIGID II and III attenuated expression of p65, a component of nuclear transcription factor kappa B. These results indicate that of the abalone intestine digests inhibit MMP-2 and MMP-9. Thus, the AIGIDs or their active components may have preventive and therapeutic potential for diseases associated with MMP-2 and MMP-9 activation in fibrosarcoma cells.
참고문헌 (26)
- Bolcato-Bellemin AL, "Expression of mRNAs encoding for alpha and beta integrin subunits, MMPs, and TIMPs in stretched human periodontal ligament and gingival fibroblasts", J Dent Res, 79, pp.1712~1716 (2000)
- Brooks SA, "Metastasis Research Protocols. Vol. 1. Analysis of Cells and Tissues" (2001), Humana Press
- Cavallaro U, "Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough", Biochim Biophys Acta, 1552, pp.39~45 (2001)
- Egeblad M, "New functions for the matrix metalloproteinases in cancer progression", Nat Rev Cancer, 2, pp.161~174 (2002)
- Ellerbroek SM, "Type I collagen stabilization of matrix metalloproteinase-2", Arch Biochem Biophys, 390, pp.51~56 (2001)
- Emara M, "Inhibition of sulfur compounds and antioxidants on MMP-2 and -9 at the activity level found during neonatal hypoxia-reoxygenation", Eur J Pharmacol, 544, pp.168~173 (2006)
- Fredrich M, "MMP-2 is involved in synaptic remodeling after cochlear lesion", Neuroreport, 21, pp.324~327 (2010)
- Hayden MS, "Signaling to NF-κB", Genes Dev, 18, pp.2195~2224 (2004)
- Hu J, "Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases", Nat Rev Drug Discov, 6, pp.480~498 (2007)
- Hwang YP, "Suppression of PMA-induced tumor cell invasion by dihydroartemisinin via inhibition of PKCalpha", Raf, AP-1-dependent mechanisms, pp.Biochem Pharmacol, 2010[DOI]
- Jezierska A, "Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review", Med Sci Monit, 15, pp.32~40 (2009)
- Kapsokefalou M, "Effects of Meat and Selected Food Components on the Valence of Nonheme Iron during In Vitro Digestion", J Food Sci, 56, pp.352~355 (1991)
- Sher Bahadar Khan, "Protective Effect of Amphiroa dilatata on ROS Induced Oxidative Damage and MMP Expressions in HT1080 Cells", Biotechnology and Bioprocess Engineering, 15(1), pp.191~198 (2010), 한국생물공학회
- Kim MM, "Effect of phloroglucinol on oxidative stress and inflmmation", Food Chem Toxicol, 48, pp.2925~2933 (2010)
- Kong CS, "Flavonoid glycosides isolated from Salicornia herbacea inhibit matrix metalloproteinase in HT1080 cells", Toxicol In Vitro, 22, pp.1742~1748 (2008)
- Kong CS, "Constituents isolated from Glehnia littoralis suppress proliferations of human cancer cells and MMP expression in HT1080 cells", Food Chem, 120, pp.385~394 (2010)
- Mendis E, "The inhibitory mechanism of a novel cationic glucosamine derivative against MMP-2 and MMP-9 expressions", Bioorg Med Chem Lett, 19, pp.2755~2759 (2009)
- Moll UM, "Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells", Cancer Res, 50, pp.6162~6170 (1990)
- Nishida Y, "Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2", Cancer Res, 68, pp.9096~9104 (2008)
- Rajapakse N, "Sulfated glucosamine inhibits MMP-2 and MMP-9 expressions in human fibrosarcoma cells", Bioorg Med Chem, 15, pp.4891~4896 (2007)
- Salo T, "Tumor-promoting phorbol esters and cell proliferation stimulate secretion of basement membrane (type IV) collagen-degrading metalloproteinase by human fibroblasts", J Biol Chem, 260, pp.8526~8531 (1985)
- Sang QX, "Matrix metalloproteinase inhibitors as prospective agents for the prevention and treatment of cardiovascular and neoplastic diseases", Curr Top Med Chem, 6, pp.289~316 (2006)
- Sternlicht MD, "How matrix metalloproteinases regulate cell behavior", Annu Rev Cell Dev Biol, 17, pp.463~516 (2001)
- Ta QV, "Inhibitory effect of chitooligosaccharides on matrix metalloproteinase-9 in human fibrosarcoma cells (HT1080)", Mar Biotechnol, 8, pp.593~599 (2006)
- Wilhelm SM, "SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages", J Biol Chem, 264, pp.17213~17221 (1989)
- Chen Zhang, "Inhibition of the expression on MMP-2, 9 and morphological changes via human fibrosarcoma cell line by 6,6'-bieckol from marine alga Ecklonia cava", BMB reports, 43(1), pp.62~68 (2010), 한국생화학분자생물학회